Avadel Pharmaceuticals Plc (AVDL)
21.64
0.00 (0.00%)
USD |
NASDAQ |
Aug 21, 16:00
Avadel Pharmaceuticals Debt to Equity Ratio
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2025 | 0.3805 |
| June 30, 2025 | 0.4194 |
| March 31, 2025 | 0.5186 |
| December 31, 2024 | 0.5004 |
| September 30, 2024 | 0.4872 |
| June 30, 2024 | 0.5359 |
| March 31, 2024 | 0.4687 |
| December 31, 2023 | 0.4033 |
| September 30, 2023 | 0.501 |
| June 30, 2023 | 0.1545 |
| March 31, 2023 | -4.066 |
| December 31, 2022 | -6.196 |
| September 30, 2022 | -11.12 |
| June 30, 2022 | -40.97 |
| March 31, 2022 | 2.628 |
| December 31, 2021 | 1.853 |
| September 30, 2021 | 1.456 |
| June 30, 2021 | 1.210 |
| March 31, 2021 | 1.052 |
| December 31, 2020 | 0.8044 |
| September 30, 2020 | 0.7536 |
| June 30, 2020 | 0.7002 |
| March 31, 2020 | 3.931 |
| December 31, 2019 | -4.269 |
| September 30, 2019 | -4.622 |
| Date | Value |
|---|---|
| June 30, 2019 | -7.634 |
| March 31, 2019 | -12.24 |
| December 31, 2018 | 41.67 |
| September 30, 2018 | 1.742 |
| June 30, 2018 | 1.440 |
| March 31, 2018 | 1.285 |
| December 31, 2017 | 0.0031 |
| September 30, 2017 | 0.0095 |
| June 30, 2017 | 0.0115 |
| March 31, 2017 | 0.014 |
| December 31, 2016 | 0.0194 |
| September 30, 2016 | 0.0277 |
| June 30, 2016 | 0.0209 |
| March 31, 2016 | 0.0167 |
| December 31, 2015 | 0.0165 |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | 5.537 |
| December 31, 2014 | 4.759 |
| September 30, 2014 | 2.396 |
| June 30, 2014 | 1.514 |
| March 31, 2014 | 0.9577 |
| December 31, 2013 | -8.993 |
| September 30, 2013 | -5.580 |
| June 30, 2013 | -8.445 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Jazz Pharmaceuticals Plc | 0.9183 |
| Perrigo Co. Plc | 1.375 |
| GH Research Plc | 0.001 |
| Cosmo NV | -- |
| Alkermes Plc | 0.8695 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 199.45M |
| Total Liabilities (Quarterly) | 101.22M |
| Shareholders Equity (Quarterly) | 98.22M |